Nationwide Fund Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-95,513	Closed	-$237K	–	1136
2017 Q3	$237K	Buy	95,513 +13,380	+16%	+$33.2K	﹤0.01%	2560
2017 Q2	$226K	Buy	82,133 +31,180	+61%	+$87.1K	﹤0.01%	2575
2017 Q1	$154K	Buy	50,953 +1,074	+2%	+$3.05K	﹤0.01%	2691
2016 Q4	$158K	Sell	49,879 -5,248	-10%	-$16.1K	﹤0.01%	2711
2016 Q3	$188K	Buy	55,127 +12,273	+29%	+$33.9K	﹤0.01%	2655
2016 Q2	$98K	Buy	42,854 +4,105	+11%	+$10.1K	﹤0.01%	2919
2016 Q1	$97K	Sell	38,749 -3,013	-7%	-$6.72K	﹤0.01%	2833
2015 Q4	$138K	Hold	41,762	–	–	﹤0.01%	2722
2015 Q3	$101K	Hold	41,762	–	–	﹤0.01%	2893
2015 Q2	$122K	Sell	41,762 -5,638	-12%	-$21.9K	﹤0.01%	2953
2015 Q1	$190K	Sell	47,400 -1,934	-4%	-$6.69K	﹤0.01%	2713
2014 Q4	$149K	Hold	49,334	–	–	﹤0.01%	2777
2014 Q3	$125K	Buy	49,334 +969	+2%	+$2.33K	﹤0.01%	2900
2014 Q2	$119K	Buy	48,365 +12,384	+34%	+$28K	﹤0.01%	2975
2014 Q1	$96K	Hold	35,981	–	–	﹤0.01%	2747
2013 Q4	$105K	Hold	35,981	–	–	﹤0.01%	2939
2013 Q3	$110K	Buy	35,981 +3,183	+10%	+$10.1K	﹤0.01%	2905
2013 Q2	$105K	Buy	+32,798	New	+$105K	﹤0.01%	2782